If you are registered for this meeting, please refer to your emails for the event access. The email subject line you are looking for is " ACCESS GRANTED: GOC’s 20th Continuing Professional Development (CPD)"

Program Objectives

  • To emphasize the importance of “Wellness” and assess the landscape of “Burnout” in medical personnel and what can be done to identify the problem and help either ourselves or colleagues in need.

  • To introduce the principle of productivity and how to develop personal strategies to improve productivity wherever applicable in daily life.

  • To summarize the three “Hot Topic” practice-changing peer-reviewed published articles of 2020.

  • To discuss the indications for maintenance therapy in ovarian cancer and the possible role of immunotherapy.

  • To review some rare types of ovarian cancer (mucinous and clear cell) and current treatment philosophies with an emphasis on future clinical research.

  • To summarize the advances in the adjuvant treatment of endometrial cancer both with respect to radiation and molecular therapy.

  • To improve the understanding of the problem of lymphedema in the gynecologic oncology population and explore the roles of the supportive care team, physiotherapy, and plastic surgery in the management of the condition.

  • To understand current projections of global cervical cancer eradication.

Wednesday, April 21st 2021

GOC Social Networking lounge: 5:30pm-6:30pm EST
 

Welcome and announcements: 6:30pm-6:35pm EST

Dr. Patti Power

 

Hot Topics of the year

Maintenance Niraparib in first-line ovarian cancer setting: 6:35pm-7:05pm EST

Dr. Anna Tinker

Learning objectives:

  • Identify the indications for maintenance Niraparib in the first-line setting 

  • Name the benefit of maintenance Niraparib

  • Anticipate and manage the common side effects of Niraparib

Stretch session: 7:05pm-7:15pm EST

Flex Space 

 

Low Grade Serous Ovarian Cancer- Trials in MEK inhibition: 7:15pm-7:40pm EST

Dr. Taymaa May

Gynecologic Oncologist

Princess Margaret Hospital

 

Learning objectives:

  • Review pathogenesis of low grade serous ovarian carcinoma

  • Discuss current management strategies of women with low grade serous ovarian carcinoma

  • Review therapeutic options for patients with low grade serous ovarian carcinoma

What is the evidence for HIPEC thus far?: 7:40pm-8:05pm EST

Dr. Joannie Neveu

Gynecologic-Oncologist – Advance Laparoscopy, and Assistant Professor

Bliss Murphy Centre, Memorial University

Learning objectives:

  • Interpret the data available in regards to oncological outcomes

  • Explain the perioperative risks and morbidities associated with HIPEC

  • List the potential challenges in universal adoption of HIPEC

Thursday, April 22nd 2021

GOC Social Networking lounge: 5:30pm-6:30pm EST

Welcome and announcements: 6:30pm-6:35pm EST

Dr. Patti Power

Mucinous Cancers of the Ovary: 6:35pm-7:00pm EST

Dr. Mark Carey

Gynecologic Oncologist

VCH

Learning objectives:

  • Review the current classifications of mucinous ovarian cancers

  • Discuss the molecular diversity of mucinous neoplasms

  • Discuss current treatment options and approaches and their limitations.

Clear Ovarian Carcinoma: New Opportunities for Treatment: 7:00pm-7:25pm EST

Dr. Hal Hirte

Medical Oncologist 

Juravinski Cancer Centre

Learning objectives:

  • Describe the pathophysiology of clear cell ovarian carcinoma

  • Review the clinical presentation Identify current treatment options

  • Discuss emerging therapies

 

Stretch Session: 7:25pm-7:35pm EST

Flex Space

Maintenance Therapy in Front Line Ovarian Cancer: Is it a PARPi for All World?: 7:35pm-8:00pm EST

Dr. Kathleen N. Moore

Stephenson Cancer Center//OUHSC

Learning objectives:

  • Differentiate the degree of benefit or lack thereof for PARPi, bevacizumab and immunotherapy maintenance in front line ovarian cancer

  • Interpret the current approved maintenance indications in Canada and how they differ from ROW

  • Differentiate the molecular profiling used across studies of PARPi efficacy and immunotherapy efficacy and where there are opportunities for improvement

  • Discuss patient populations where clinical equipoise re maintenance exists and how clinical trials may move us forward.

Strategies and System Change to Mitigate Physician Burnout: 8:00pm-9:00pm EST

Dr. Caroline Gérin-Lajoie

Canadian Medical Association

Learning objectives:

  • Define and recognize signs and symptoms of burnout in ourselves and others

  • Identify the potential impact of burnout on individuals and on the health care system

  • Demonstrate individual and organizational strategies to decrease burnout and increase resilience

Friday, April 23rd 2021

Welcome and announcements: 6:30pm-6:35pm EST

Dr. Patti Power

Hyperfocus: How to Be More Productive in a World of Distraction: 6:35pm-7:30pm EST

Mr. Chris Bailey

 

Stretch Session: 7:30pm-7:40pm EST

Flex Space

Molecular Classification in Endometrial Cancer: ProMisE for Informed Adjuvant Therapy: 7:40pm-8:05pm EST

Dr. Stephen Welch

Medical Oncologist

London Regional Cancer Program

Learning objectives:

  • Review data to support prognostic implications of established molecular classifiers in endometrial cancer.

  • Demonstrate the utility of application of these biomarkers in adjuvant therapy decision-making for resected endometrial cancer, based on data from randomized controlled trials.

  • Identify the role of molecular classifiers in prospective clinical trials to further improve the outcomes for patients with endometrial cancer.

GOC Social Networking lounge: 8:00pm-8:30pm EST

Saturday, April 24th 2021

GOC Social Networking lounge: 10:00am-10:35am EST

Welcome and announcements: 10:35am-10:40am EST

Dr. Patti Power

Global elimination of cervical cancer - opportunities & challenges: 10:40am-11:05am EST

Dr. Partha Basu, MD, PhD

Deputy Head, Early Detection & Prevention Branch

International Agency for Research on Cancer

World Health Organization

Learning objectives:

  • Review the strategies for cervical cancer elimination globally

  • Describe the roadmap to cervical cancer elimination

  • Assess the opportunities created by the availability of highly effective vaccines and improved screening algorithms

  • Evaluate the challenges faced by the fragile health systems in the low and middle-income countries to organise the services with quality and equity

  • Describe how global partnerships can create a 'win win' situation to advance the global elimination of the cancer

Cancer physiatry & considerations in palliative lymphedema: 11:05am-11:30am EST

Dr. George Francis, MD, FRCPC, CSCN(EMG)

Cancer Physiatrist, The University of Calgary 

Learning objectives:

  • Define cancer rehabilitation and name 5 cancer-related impairments that physiatry can address. 

  • Review 3 benefits of manual lymphatic drainage in the palliative cancer patient.

  •  Identify 3 lymphatic devices/garments that can be helpful in the palliative setting.

The Nature of Lymphedema: Management and Prevention: 11:30am-11:55am EST

Ms. Natasha Grant

Physiotherapist,  Jewish General Hospital

Learning objectives:

  • Comprehend the role of physiotherapy in detecting and treating lymphedema.  

  • Identify three interventions physiotherapists use to treat lymphedema.

  • Describe two indications for referral to a lymphedema specialist.

 

Stretch Session: 11:55am-12:05pm EST

Flex Space

Novel surgical treatments for secondary lymphoedema: 12:05pm-12:30pm EST

Dr. Marie-Pascale Tremblay-Champagne

Plastic surgeon, University of Montreal

Learning objectives:

  • Summarize the 2 most common microsurgical procedures for lymphedema: vascularized lymph node transfers and lymphatic ovenous anastomoses

  •  Identify patients who may be candidates for these surgical procedures  

  • Predict realistic benefits from these surgical procedures, in order to better counsel patients

Closing remarks: 12:30pm EST

Dr. Patti Power